The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Genetic factors in human obesity
Abstract
The recent increase in the prevalence of obesity in many parts of the world is clearly driven by secular changes in exposure to environmental factors, including the increased availability and reduced costs of energy-dense food and a reduction in physical activity during work and leisure time (1, 2). The speed with which this 'obesity epidemic' has occurred has led to the widespread misconception that heritable factors play an insignificant role in determining which humans become obese. In fact, measures of fatness (also known as adiposity) are among the most heritable of human traits (3). Multiple studies of families, adoptees, twins and, most powerfully, adopted twins (4, 5) have all confirmed that heritable factors are likely to be responsible for 45–75% of the inter-individual variation in body mass index (the commonly used measure of adiposity) (3, 6-8). These heritable factors are likely to be multiple and are likely to operate through the full range of potential mechanisms, including energy intake, energy expenditure and the partitioning of nutrients between fat and lean tissue. Paradoxically, there is a danger that the effects of such hereditary influences on weight will be downplayed at a time when we are beginning, for the first time, to have a genuine understanding of the molecules involved in the control of body weight and how genetic variation in them can influence human obesity. The discovery of obesity genes will undoubtedly lead to health benefits. These will come in at least three ways. First, some genetic obesity syndromes are very severe, occur at a young age and are associated with other developmental and clinical manifestations (9). Knowledge of the underlying genetic defect in these syndromes will greatly aid genetic counselling. As illustrated by the dramatic benefits of recombinant leptin in congenital leptin deficiency (10), such discoveries may also lead to the development of mechanism-based forms of effective therapy for these uncommon disorders. Second, genetic studies can help reveal novel molecular pathways controlling human energy balance and thereby clarify the relevance of such pathways as targets for pharmacological intervention in more common forms of obesity (11, 12). Third, it is possible that, by recognizing common genetic variants that predispose to obesity through different mechanisms, we may be able to classify obese subjects into subgroups that might have particularly beneficial responses to specific diets and/or exercise regimes, drugs or surgery. Progress to date has mostly been in more severe familial forms of obesity presenting in childhood. Although these only represent a small fraction of those with obesity (albeit a group with disproportionate physical and psychosocial morbidity and health costs), the implications of these discoveries have been profound. The genetic defects found to date all impair satiety, affecting the function of appetite control centres in the brain rather than being due to a 'slow metabolism' (13). This indicates that we must think of human food intake not as an entirely voluntarily controllable phenomenon but one driven by powerful biological signals from relatively primitive brain areas. When these basic signalling mechanisms are severely disrupted, it is very difficult to overcome the drive to eat. Importantly, the discovery of these genetic disorders has helped de-stigmatize human obesity and allowed it to be seen as a biomedical disorder and not simply a moral frailty. In one case, discovery of the causative genetic defect has led to dramatically successful therapy in a few individuals (10, 14). Finally, mutations in one gene, the melanocortin 4 receptor, may be responsible for tens of thousands of cases of obesity in the UK alone (15, 16). Knowledge of the specific molecular mechanisms in this and other genetic disorders should lead to better mechanism-directed pharmacotherapy in the future. Given the undoubted environmental influences on obesity in the general population, the multiple molecular mechanisms that could influence adiposity and the unknown genetic architecture of obesity susceptibly, it is unsurprising that progress in the identification of genes influencing susceptibility to common forms of obesity has been slower. It is not yet clear whether the genetic architecture of common obesity will conform more to the 'common variant–common disease' model, in which some relatively common polymorphisms have modest but widespread effects on risk, or the 'multiple rare variants–common disease' model, where multiple different rare alleles underlie genetic susceptibility (17). Polymorphisms in multiple candidate genes, selected by virtue of their known biological function and/or their role in the causation of monogenic obesity syndromes in humans or animal models, have been examined in population and case–control studies to determine whether they influence the risk of adiposity. The Trp64Arg variant in the Beta-3 adrenergic receptor
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998
Self-citationGenetic and Environmental Factors in Relative Body Weight and Human Adiposity
Maes, H. H. M., Neale, M. C., & Eaves, L. J. (1997) · Behavior Genetics · doi:10.1023/a:1025635913927 · Cited by 1,515
An Adoption Study of Human Obesity
Stunkard, A. J., Sørensen, T. I. A., Hanis, C., Teasdale, T. W., Chakraborty, R., Schull, W. J., & Schulsinger, F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601233140401 · Cited by 1,318
The Body-Mass Index of Twins Who Have Been Reared Apart
Stunkard, A. J., Harris, J. R., Pedersen, N. L., & McClearn, G. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005243222102 · Cited by 1,286
Stunkard, A. J. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380010055024 · Cited by 912
A common genetic variant is associated with adult and childhood obesity.
Herbert, A., Gerry, N. P., McQueen, M. B., Heid, I. M., Pfeufer, A., Illig, T., Wichmann, H.-E., Meitinger, T., Hunter, D., Hu, F. B., et al. (2006) · Science · doi:10.1126/science.1124779 · Cited by 732 · cited 1×
“(32) have identified an SNP close to the Insig2 gene which, when present in homozygous form, increases the odd ratio for obesity by 1.”
Background
Cited by
Bray, G. A., Kim, K. K., Wilding, J. P. H., & on behalf of the World Obesity Federation (2017) · Obesity Reviews · doi:10.1111/obr.12551 · Cited by 1,612
Meyre, D., Delplanque, J., Chèvre, J.-C., Lecoeur, C., Lobbens, S., Gallina, S., Durand, E., Vatin, V., Degraeve, F., Proença, C., et al. (2009) · Nature Genetics · doi:10.1038/ng.301 · Cited by 652
Bariatric surgery: an IDF statement for obese Type 2 diabetes
Dixon, J. B., Zimmet, P., Alberti, K. G., Rubino, F., & on behalf of the International Diabetes Federation Taskforce on Epidemiology and Prevention (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03306.x · Cited by 494
Dietary Sugar and Body Weight: Have We Reached a Crisis in the Epidemic of Obesity and Diabetes?
Bray, G. A., & Popkin, B. M. (2014) · Diabetes Care · doi:10.2337/dc13-2085 · Cited by 417
Pospisilik, J. A., Schramek, D., Schnidar, H., Cronin, S. J. F., Nehme, N. T., Zhang, X., Knauf, C., Cani, P. D., Aumayr, K., Todoric, J., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.027 · Cited by 368
Metadata
- Authors
- Farooqi, I. S., & O’Rahilly, S.
- Venue
- Obesity Reviews
- Publisher
- Wiley
- Published
- 2007-02-19
- Volume
- 8
- Issue
- s1
- Pages
- 37-40
- ISSN
- 1467-7881 (ISSN-L)
- 1467-789X
- OpenAlex
- W2121126323
- Cited by
- 184
- References
- 6
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic factors in human obesity. https://app.cochat.ai/papers/10.1111/j.1467-789x.2007.00315.x
- The paper
- Farooqi, I. S., & O’Rahilly, S. (2007). Genetic factors in human obesity. Obesity Reviews. https://doi.org/10.1111/j.1467-789x.2007.00315.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.